Johnson & Johnson JNJ earnings Q4 2020

Johnson & Johnson Coronavirus vaccine illustration

Dado Ruvic | Reuters

Johnson & Johnson on Tuesday reported fourth-quarter earnings and revenue that beat Wall Street’s expectations.

Here’s how J&J did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:

  • Adjusted EPS: $1.86 per share versus $1.82 expected.
  • Revenue: $22.48 billion versus $21.67 billion expected.

“I’m incredibly proud of our Johnson & Johnson teams around the world for going above and beyond to meet stakeholder needs,” J&J CEO Alex Gorsky said in a press release. “We continue to progress our COVID-19 vaccine candidate and look forward to sharing details from our Phase 3 study soon.”

This is a developing story. Please check back for updates.

Source link




Netflix, Interactive Brokers and Zions

A picture of a woman starting Netflix on a TV inside her apartment.Artur Widak | NurPhoto | Getty ImagesCheck out the companies making...

Mercedes-AMG SL spy shots show it will get S-Class infotainment tech

Mercedes-Benz has gone so far as to release its own “spy shots” of the upcoming SL Roadster, but one of our spy shooters...

Too soon to say if Germany will extend Covid lockdown: Health minister

German Health Minister Jens Spahn told CNBC on Wednesday it's "too early to say" whether the country will extend its partial lockdown beyond...